Files

892056.pdf (3.03 MB)

Document type

Article

Version

Accepted version

Publication date

2025-04-01

Publication license

(c) Taylor & Francis, 2025
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220360

Hepatocellular carcinoma: what are the differential costs compared to the general population?

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/https://doi.org/10.1080/13696998.2025.2484073

Abstract

Hepatocellular carcinoma (HCC), which accounts for about 90% of all primary liver can-cer cases, is the fifth most common malignancy and the second leading cause of cancer-related mor-tality worldwide. This study aims to analyse the differential costs of HCC-related hospital admissionscompared to the general population in Spain (...)

Subject

Hepatologia, Control de costos, Carcinogènesi, Economia de la salut, Política sanitària

Subject (English)

Hepatology, Cost control, Carcinogenesis, Medical economics, Medical policy

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep and ASCANIO, Meritxell. Hepatocellular carcinoma: what are the differential costs compared to the general population?. Journal of Medical Economics. 2025. Vol. 28, num. 1, pags. 471-478. ISSN 1369-6998. [consulted: 13 of June of 2026]. Available at: https://hdl.handle.net/2445/220360

Export metadata

JSON - METS

Share record